Analyst firms · Raymond James · EW
Raymond James EW price target and rating history
Edwards Lifesciences Corporation (EW) · Health Care
Raymond James rates Edwards Lifesciences Corporation (EW) Outperform with a $96 price target, as of its latest action on Nov 3, 2025. It has published 6 rating actions on EW since August 2021, including 1 upgrade and 1 downgrade. Across 7 firms with a EW price target in the last 12 months, the median target is $110.
- Current rating
- Outperform
- Price target
- $96
- Median target, all firms
- $110
- Actions on EW
- 6
Raymond James price target on EW
Every Raymond James rating on EW
- Nov 3, 2025
- Feb 6, 2023
- Jan 27, 2022
- Dec 10, 2021
- Oct 28, 2021
- Aug 2, 2021
How other firms rate EW
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Robert W. Baird | Outperform | $116 | Nov 5, 2026 |
| Truist Securities | Buy | $113 | Nov 4, 2026 |
| Barclays | Overweight | $110 | Oct 7, 2026 |
| UBS | Buy | $110 | Jul 28, 2026 |
| Leerink Partners | Outperform | $101 | Jul 24, 2026 |
| Wolfe Research | Outperform | $92 | Apr 1, 2026 |
| TD Cowen | Buy | $97 | Jan 9, 2026 |
Questions about Raymond James and EW
- What is Raymond James's price target for EW?
- Raymond James's latest stated price target for Edwards Lifesciences Corporation (EW) is $96, from its action on Nov 3, 2025.
- What is Raymond James's rating on EW?
- Raymond James rates EW Outperform, a bullish rating, as of Nov 3, 2025.
- When did Raymond James last change its view on EW?
- On Nov 3, 2025, Raymond James upgrades to Outperform from Mkt Perform, price target $96.
- How does Raymond James's EW target compare with other analysts?
- Across 7 firms with a EW price target in the last 12 months, the median target is $110.
More EW rating histories
- Robert W. Baird3
- Truist Securities3
- UBS5
- Leerink Partners6
- Wolfe Research6
- Jefferies4
- Oppenheimer4
- Evercore ISI3
- Piper Sandler4
- Stifel4
- BofA Securities4
- Morgan Stanley6
- Citigroup4
- Wells Fargo6
- Credit Suisse3
All Raymond James ratingsEW news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.